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Abstract Addition of creatine to the di¡erentiation medium of
C2C12 cells leads to hypertrophy of the myotubes. To investigate
the implication of insulin-like growth factor I (IGF-I) and myo-
genic regulatory factors (MRFs) in this hypertrophy, their
mRNA levels were assessed during the ¢rst 72 h of di¡erentia-
tion. Creatine signi¢cantly increased the IGF-I mRNA level
over the whole investigated period of time, whereas the MRF
mRNA levels were only augmented at precise moments, suggest-
ing a general activation mechanism for IGF-I and a speci¢cally
regulated mechanism for MRF transcription. Our results sug-
gest therefore that creatine-induced hypertrophy of C2C12 cells
is at least partially mediated by overexpression of IGF-I and
MRFs.
, 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Already in 1972, Ingwall et al. reported that creatine (Cr)
stimulated incorporation of labelled precursor into myosin
heavy chain, the major myo¢brillar protein, and stimulated
muscle-speci¢c protein synthesis in both skeletal and cardiac
chicken myotubes in culture [1,2]. In another paper, one of
Ingwall’s co-authors failed to ¢nd any regulatory e¡ect of Cr
on total protein synthesis in cultured muscle cells [3]. So these
early observations have not been con¢rmed over a 30 year
period of time, until recently when it was shown that the
fusion of myogenic satellite cells is largely enhanced while
creatine monohydrate is added to the culture medium during
the di¡erentiation phase [4].
The mechanism(s) by which Cr stimulates muscle protein
synthesis remain(s) unknown. Insulin-like growth factor
(IGF)-I is a small peptide growth factor similar in structure
to pro-insulin which plays a major role in the control of
muscle growth [5]. IGF-I is produced by liver, under the con-
trol of growth hormone, and is released in blood circulation
as an endocrine hormone. Skeletal muscle also produces IGF-
I that acts as a paracrine and autocrine growth factor. Over-
expression of IGF-I by injection of a plasmid or a viral con-
struct containing IGF-I cDNA into a mouse muscle has been
shown to increase muscle mass (15%) and to prevent sarco-
penia in old mice [6]. Since the di¡erentiation of myoblasts in
culture is stimulated by Cr [4], we hypothesised that IGF-I
might be involved in the e¡ect of Cr.
The initiation of muscle di¡erentiation is governed among
others by myogenic regulatory factors (MRFs). The MRFs,
which include Myo-D, Myf-5, MRF-4 and myogenin, are
members of a family of basic helix-loop-helix proteins that
act as transcription activators due to their inherent properties
as DNA binding proteins. Their binding to DNA initiates the
transcription and regulates the expression level of some
muscle-speci¢c genes, such as myosin heavy and light chains,
K-actin, or creatine kinase [7]. The speci¢c roles of the di¡er-
ent MRFs in skeletal muscle di¡erentiation have not yet been
completely de¢ned, essentially due to the existence of auto-
and cross-regulatory loops between them [8^11]. However,
Myo-D and Myf-5 are early factors, mainly involved in myo-
blast formation and in satellite cell proliferation during regen-
eration, while myogenin and MRF-4 are late-acting factors,
expressed during di¡erentiation [12].
The purpose of this study was to test the role of IGF-I and
MRFs in the hypertrophic e¡ect of Cr added to the culture
medium of C2C12 cells, during the ¢rst 72 h of di¡erentiation.
2. Materials and methods
2.1. Cell culture
The murine C2C12 myoblast cell line (ATCC, Manassas, VA, USA)
was propagated in proliferating Dulbecco’s modi¢ed Eagle’s medium
(DMEM; Life Technologies, Merelbeke, Belgium) supplemented with
10% foetal bovine serum, penicillin/streptomycin (5000 U/5000 Wg/ml)
and non-essential amino acids (1%). To induce myogenic di¡erentia-
tion, myoblasts were allowed to grow to approximately 70% con£u-
ence and then switched to di¡erentiation medium (DMEM with 2%
horse serum, penicillin/streptomycin, 5000 U/5000 Wg/ml, and non-
essential amino acids 1%). Plates (10 cm diameter, Nunc) were grown
in duplicate, and half received Cr (see below) in di¡erentiation me-
dium.
2.2. Protein quanti¢cation
To establish the optimal Cr concentration to add in the medium,
cells were cultivated with increasing doses of Cr (0, 1, 5, 10 and 20
mM, n=3) in di¡erentiation medium. After 48 h of di¡erentiation, the
medium was removed by aspiration and the cells were washed with
cooled phosphate-bu¡ered saline (PBS). Myotubes were removed
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from the plates by addition of 3 ml trypsin (0.5% EDTA, Invitrogen)
per plate. After centrifugation, protein pellet was dissolved in 1 ml
NaOH 1 N and incubated at 37‡C for 12 h. Soluble protein contents
of the solutions were determined by spectrophotometric method using
a biuret-like reaction (Protein Assay ESL, Boehringer Mannheim kit).
After the proliferation, all cells were pooled and then redistributed in
several plates. Therefore the number of cells in each plate is believed
to be the same and any variation of the protein content can be attrib-
uted to the treatment.
2.3. Diameter of myotubes
Five pictures of each plate were recorded. The average diameters of
myotubes were measured manually from the cells crossing a diagonal
drawn on the picture.
2.4. RNA extraction and real-time quantitative polymerase chain
reaction (RTQ-PCR)
Cells were cultured for 0, 24, 48 and 72 h in di¡erentiation medium,
with or without 5 mM Cr. At each time point, plates (n=4) were
rinsed twice with cooled PBS and total RNA was isolated from cells
culture using TRIzol0 reagent (Gibco Life Technologies, Paisley, UK)
according to the manufacturer’s instructions. RNA was quanti¢ed by
spectrophotometry (V=260 nm) and its concentration adjusted to 0.25
Wg/Wl using RNase-free water. Reverse transcription using 1 Wg of
total RNA was done as previously described [13]. RTQ-PCR primers
were designed (Primer Express Software, Applied Biosystems) for
mouse IGF-I, Myo-D, Myf-5, MRF-4, myogenin, and L2-microglo-
bulin as housekeeping gene (Table 1). Preliminary experiments of our
group showed that L2-microglobulin mRNA was stable in samples
incubated with Cr. RTQ-PCR was carried out using the following
cycle parameters: 10 min at 95‡C, followed by 40 cycles of 1 min at
60‡C and 15 s at 95‡C. For each gene, RTQ-PCR was conducted in
duplicate with 25 Wl reaction volume of 1 ng cDNA. To ensure the
quality of the measurements, each plate included for each gene a
negative control and a positive control [13]. The threshold cycle
(Ct) from a positive sample was used to calculate the inter-assay
coe⁄cient of variation (CV). For each gene, the CV was calculated
as standard deviation/mean of 2-Ct determined on ¢ve di¡erent plates
and with di¡erent mixes. Typically the CV obtained was around 16%.
The IGF-I primers were designed to recognise all the IGF-I iso-
forms. The mRNA levels were normalised by assigning an arbitrary
value of 100% to the mRNA level observed at the beginning of the
experiment (0 h).
2.5. Statistics
The e¡ect of Cr was tested by an ANOVA design. Student’s t-test
was used as post hoc. The signi¢cance threshold was set to 0.05. The
results are presented as meanTS.E.M.
3. Results
Our results show that adding Cr to the di¡erentiation me-
dium of C2C12 cells induces a general hypertrophy of myo-
tubes (Fig. 1). After 2 days of di¡erentiation, their diameter
was 40% larger in the presence of Cr (P6 0.001). This hyper-
trophy was associated with increased protein accumulation.
Increasing concentrations of Cr to 10 mM signi¢cantly in-
creased protein content (P6 0.05) that returned to the control
level with 20 mM Cr (Fig. 2). Because 5 mM Cr induced the
maximal e¡ect on protein accumulation, the experiments were
performed by adding 5 mM Cr to the di¡erentiation medium.
IGF-I mRNA as well as mRNA of the four MRFs (Myo-
D, Myf-5, MRF-4 and myogenin) were detectable and quan-
ti¢able at each time point we investigated.
In control conditions, the level of IGF-I mRNA exhibited a
steady-state level throughout the ¢rst 3 days of di¡erentiation
Table 1
Primers used for RTQ-PCR. Slope and correlation of standard curve.
Primer name Sequence (5P to 3P) Accession number Slope Correlation
L2-Microglobulin Fw TGC TAT CCA GAA AAC CCC TCA NM_009735 33.37 30.999
L2-Microglobulin Rv GCG GGT GGA ACT GTG TTA CG
IGF-I Fw GCT ATG GCT CCA GCA TTC G NM_010512 33.39 30.998
IGF-I Rv TCC GGA AGC AAC ACT CAT CC
Myo-D Fw TCC GTG TTT CGA CTC ACC AG NM_010860 33.12 30.994
Myo-D Rv AGA AGT GTG CGT GCT CTT CC
Myf-5 Fw CTG CCA GTT CTC CCC TTC TG NM_008656 32.97 30.992
Myf-5 Rv CCG AAG GCT GCT ACT CTT GG
MRF-4 Fw GTG GCC AAG TGT TTC GGA TC NM_008657 32.88 30.995
MRF-4 Rv AAA GGC GCT GAA GAC TGC TG
Myogenin Fw TGA GCA TTG TCC AGG CCA G NM_031189 33.8 30.998
Myogenin Rv GCT TCT CCC TCA GTG TGG CT
Fig. 1. C2C12 cell hypertrophy induced by Cr. At 70% con£uence, C2C12 myoblasts were exposed for 48 h to di¡erentiation medium containing
5 mM Cr. Scale bar, 100 Wm.
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(Fig. 3). However, when cells were incubated with 5 mM Cr,
the level of IGF-I mRNA increased progressively to be multi-
plied by 3.7 after 72 h (ANOVA, P=0.041).
The level of Myo-D mRNA remained stable in control and
Cr conditions over the ¢rst 48 h of di¡erentiation. Neverthe-
less, after 72 h, the mRNA level of Myo-D increased up to
150% in control conditions, and to 200% with Cr (ANOVA,
P=0.001).
In contrast, Myf-5 mRNA increased in control conditions
by 75% one day after cells were placed in di¡erentiation me-
dium and returned to control level the next day. The increase
was potentiated by adding Cr in the di¡erentiation medium
(ANOVA, P=0.040). After 24 h di¡erentiation, Myf-5
mRNA level reached 230% compared to Ctrl 0 h. Afterwards,
it returned to a level similar to control 0 h in both conditions.
This means that the reduction in Myf-5 mRNA between 24 h
and 48 h of di¡erentiation was faster when C2C12 cells were
incubated with Cr.
As soon as the fusion process was initiated, the level of
myogenin mRNA increased continuously in control condi-
tions, reaching a 90-fold increase after 72 h of di¡erentiation.
Fig. 2. Dose^response relationship between Cr concentrations and
myotube protein content. At 70% con£uence, C2C12 myoblasts were
exposed for 48 h to di¡erentiation medium containing di¡erent con-
centrations of Cr. After 48 h, cells were collected and cell protein
concentrations were assayed as described in Section 2. Results are
expressed as meanTS.E.M. (n=3). *P6 0.05 vs Ctrl conditions (Cr
0 mM).
Fig. 3. IGF-I and MRF mRNA expression. At 70% con£uence, C2C12 myoblasts were exposed for di¡erent periods of time to di¡erentiation
medium with (grey bars) or without 5 mM Cr (black bars). After 0, 24, 48 and 72 h of di¡erentiation, cells were collected and gene expression
levels for Myf-5, Myo-D, myogenin and MRF-4 were assessed by RTQ-PCR as described in Section 2. A value of 1 was arbitrarily assigned to
the control conditions (ctrl 0 h). Results are expressed as meanTS.E.M. Statistical di¡erences are assessed by Student’s t-test: *P6 0.05;
**P6 0.01, Ctrl vs Cr conditions.
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This marked induction was even more pronounced in the
presence of Cr, reaching a 140-fold increase after 3 days.
However, due to the small number of samples and the large
variation, the signi¢cance threshold was not reached.
Finally, the level of MRF-4 mRNA remained stable during
the ¢rst 3 days of di¡erentiation. Nevertheless, on the third
day, MRF-4 mRNA showed an increase of 230% in the pres-
ence of Cr (ANOVA, P=0.049). For all MRFs tested, Cr
addition potentiates the induction stimulated by the switching
to di¡erentiation medium of C2C12 cells.
4. Discussion
In this study, we investigated the e¡ect of Cr in C2C12
myogenic cells during the ¢rst 72 h of di¡erentiation. In the
presence of Cr, the average diameter of myotubes was in-
creased suggesting that Cr enhances di¡erentiation of C2C12
cells. The dose^response relationship shows that 5 mM Cr in
the medium is the optimal amount. This level of Cr is very
high compared with the normal physiological range of con-
centrations (0.05^0.5 mM). It could elicit various cell re-
sponses among which a cellular swelling due to a higher os-
motic pressure followed by a regulatory volume decrease
[14,15]. The subsequent stretching of membrane could initiate
the stimulation of protein synthesis [16]. It is possible that the
cell is unable to regulate its volume when larger amounts of
Cr are added in the medium (20 mM). This could explain why
the protein content was lower in myotubes grown with 20 mM
Cr in comparison to those grown with 5 mM Cr, although
their diameters were similar.
In any case, our results con¢rm that Cr stimulates growth
and protein accumulation in myogenic cells in culture [1,4].
To assess the role of IGF-I and the MRFs in this trophic
e¡ect, we investigated the time course of the induction of their
gene expression by Cr.
The sequence of MRF mRNA activation that we observed
is similar to the previously reported sequence for MRF pro-
tein expression during di¡erentiation [12]. It is commonly ac-
cepted that Myo-D and Myf-5 are already highly expressed in
undi¡erentiated myogenic cells before the di¡erentiation pro-
gramme is activated [17,18] while myogenin and MRF-4 are
rather late-acting factors, expressed during the di¡erentiation
(Fig. 3). Our results indicate that Myf-5 mRNA still increases
during the ¢rst 24 h of di¡erentiation whereas the level of
Myo-D mRNA remains much more stable showing only a
slight increase after 72 h. Moreover, our results show that
Cr stimulates the transcription of all MRFs tested. As Dedieu
et al. [12] proposed the existence of a threshold level of MRF
expression to initiate the fusion step, our results support the
idea that this threshold level is reached earlier in the presence
of Cr, allowing the myoblasts to di¡erentiate more rapidly
and attain swiftly the fusion step.
In contrast to MRF expression, IGF-I mRNA remained
unchanged in control conditions while it rose about three-
fold after 72 h of incubation with Cr. Although it still remains
unknown how Cr could activate the transcription of the IGF-
I gene, the signalling pathways used by IGF-I to stimulate
muscle growth has been recently characterised. The hypertro-
phic e¡ect of IGF-I is mediated through the phosphatidyl-
inositol 3-kinase (PI3K)-Akt pathway [19], which leads to
an increase in protein synthesis through the phosphorylation
of p70S6k, a key regulator of S6 ribosomal subunit activity.
Moreover, IGF-I also contributes to myogenesis by activating
myogenin through the PI3K-Akt pathway [19]. On the other
hand, a role of the mitogen-activated protein kinase [20] and
the calcineurin pathways has also been suggested in the hyper-
trophic e¡ect of IGF-I [21]. In the presence of Cr, the level of
IGF-I mRNA was increased over the whole investigated peri-
od of time (72 h), whereas the mRNA levels of the various
MRFs were only augmented at precise moments (Fig. 3),
suggesting a general activation mechanism for IGF-I and a
much more regulated mechanism for MRF transcription. All
together, our observations raise the possibility that IGF-I
might mediate the e¡ects of Cr on growth and di¡erentiation
of myogenic cells in culture.
Interestingly, clenbuterol, which exerts powerful anabolic
e¡ects on skeletal muscle, also stimulates IGF-I expression
[22] and Cr accumulation in myoblasts in culture [23]. To
date, the mechanism by which clenbuterol increases IGF-I
remains unknown, but could be mediated by the accumulation
of Cr within the cell.
Although it is likely that the responses of C2C12 cells di¡er
strongly from those of human mature muscle ¢bres, the ability
of Cr to stimulate MRFs has also been demonstrated in vivo.
Recently, resistance training in humans was shown to increase
the level of myogenin and MRF-4 mRNA in the vastus late-
ralis muscle, an increase potentiated by oral Cr supplementa-
tion [24]. Furthermore, Hespel and al. [25] examined the e¡ect
of oral Cr supplementation on MRF expression during hu-
man leg immobilisation and rehabilitation. Their results
showed that myogenin protein expression was increased after
rehabilitation in placebo but not under Cr supplementation,
while MRF-4 protein expression was increased with Cr but
not with placebo. So, the e¡ects of Cr on MRFs are not only
observed in myogenic cell culture, but are also present in vivo,
even if results in humans are contradictory for myogenin,
probably due to the experimental protocols (rehabilitation
vs training, and delays for biopsies). Nevertheless, the direct
linkage between results from cultures of myogenic cells and
from adult humans should be taken with caution.
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